Clinical trial
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
NCT00032968 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00032968 |
|---|---|
| Title | Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1 |
| Official title | Buprenorphine/Naloxone Versus Clonidine For Out-patient Opiate Detoxification |
| Lead sponsor | University of California, Los Angeles, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heroin Dependence, Morphine Dependence, Substance Withdrawal Syndrome |
| Intervention type | Drug |
| Interventions | Buprenorphine/naloxone |
| Enrollment | 341 |
| Start date | Jan 1, 2001 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Apr 8, 2002 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: